[6]. Siena S, et al. Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) Oncogene in Colorectal Cancer. Ann Oncol. 2018 May; 29(5):1108-1119. [7]. Yan M, et al. HER2 expression status in diverse cancers: review of results from 37,992 patients. Cancer Metastasis Rev. 201...
[9] Suzuki M, Kasajima R, Yokose T, Ito H, Shimizu E, Hatakeyama S, et al.. Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component. Transl Lung Can...
[24].Tan AC, Saw SPL, Chen J, et al. Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer. JCO Preci...
[24].Tan AC, Saw SPL, Chen J, et al. Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2022;6:e2200278. doi:10.1200/PO.22.00278 [25].Shepherd FA, Da...
[9] Suzuki M, Kasajima R, Yokose T, Ito H, Shimizu E, Hatakeyama S, et al.. Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component. Transl Lung Cancer Res (2021) 10(3):1292–304. ...
[24].Tan AC, Saw SPL, Chen J, et al. Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2022;6:e2200278. doi:10.1200/PO.22.00278 ...
DESTINY-Lung02研究结果显示,Enhertu治疗HER2阳性非小细胞肺癌的缓解率(ORR)为58%,中位缓解持续时间(DOR)为8.7个月。 4. 结直肠癌 2022年开展的美国临床肿瘤学会胃肠道肿瘤研讨会(ASCO GI)上,研究人员公布了Enhertu治疗HER2阳性不可切除性和/或转移性结直肠癌的效果。研究结果显示,Enhertu治疗的缓解率为45.3%...
4.Pillai R, et al. HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium. Cancer. 2017;1;123(21): 4099-4105. 5.Yan M, et al. HER2 expression status in diverse cancers: review of results from 37,992 patients. Cancer Metastasis Rev. 2015 Mar;34(1)...
1. Min Yan , Maria Schwaederle, David Arguello,et al. HER2 expression status in diverse cancers: review of results from 37,992 patients[J]. Cancer Metastasis Rev,2015 Mar;34(1):157-64. 2. Yu Y, Yang Y, Li H, Fan Y. Targeting HER2 alterations in non-small cell lung cancer: Thera...
Korrapati V,Gaffney M,Larsson LG,et al.Effect of HER2/neu expression on survival in non-small cell lung cancer. Clinical Lung Cancer Journal . 2001Korrapati V,Gaffney M,Larson LG. Effect of HER2/neu expression on survival in non-small lung cancer[J].Clinical Lung Cancer 2001,2....